Delivery Order SPM20005D3101-KZ24
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a major pharmaceutical and medical supplies distributor. The $136,518.61 contract is for the provision of various pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to support the TRICARE West program, which provides healthcare services to military members, retirees, and their families. Cardinal Health has a long-standing relationship...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $78,302.45 firm fixed-price delivery order is for the supply of various pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to support the TRICARE West program. Cardinal Health has a long-standing relationship with the U.S. government, providing pharmaceutical distribution services under the...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $107,907.27 firm fixed-price delivery order is for the supply of a variety of pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to support the TRICARE West program. Cardinal Health has a long-standing relationship with the Department of Defense (DoD),...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for the provision of pharmaceutical and medical supply distribution services under the TRICARE West program. The contract, valued at $177,079.43, is a firm fixed-price delivery order with no set-aside designation. Cardinal Health, a large for-profit healthcare services and products company, has a long-standing relationship with the federal government, particularly the Department of Defense...
- This federal contract award is to Cardinal Health, Inc., a global healthcare services and products company, from the Defense Logistics Agency (DLA) under the TRICARE WEST program. The $86,993.79 firm fixed-price delivery order is for the supply of a variety of pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to military treatment facilities and deployed troops worldwide. The contract is part of the DLA's Pharmaceutical Prime Vendor program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Cardinal Health, Inc. for the TRICARE West program. The $75,356.64 contract is for the delivery of various pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to military treatment facilities and deployed troops worldwide. Cardinal Health, a large for-profit healthcare services and products company, has a long-standing relationship with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $77,347.73 firm fixed-price delivery order contract is for the supply of various pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to support the TRICARE WEST program. Cardinal Health is a long-standing federal contractor, with a focus on providing pharmaceutical distribution services to...
- The federal contract award, SPM20005D3103|M290, was granted to Cardinal Health, Inc. by the Defense Logistics Agency (DLA) for the TRICARE WEST program. The $587,760.00 firm fixed-price delivery order is for the supply of various pharmaceutical products, including prescription medications, over-the-counter drugs, vaccines, and radiopharmaceuticals, to support military treatment facilities and deployed troops worldwide. Cardinal Health holds an indefinite delivery contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, for the provision of pharmaceutical distribution services under the TRICARE West program. The single-award, firm fixed-price delivery order, valued at $147,969.02, does not have a set-aside designation, reflecting Cardinal Health's status as a large, for-profit organization. The contract is part of the DLA's Pharmaceutical Prime Vendor program,...
- This federal contract award, valued at $82,640.38, was made by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for the provision of pharmaceutical and medical supplies under the TRICARE West program. The contract is a firm fixed-price delivery order, with no set-aside designation. Cardinal Health, a large for-profit organization, has a long-standing relationship with the federal government, particularly the Department of Defense (DoD), Department of Veterans Affairs (VA), and...
- SPM20005D3101Indefinite Delivery Contract
- SPM20005D3101-KZ24Delivery Order
This is a federal contract award to Cardinal Health, Inc., a global healthcare services and products company, by the Defense Logistics Agency (DLA) under the TRICARE WEST program. The $151,726.30 firm fixed-price delivery order contract is for the supply of a variety of pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to military treatment facilities and deployed troops worldwide. Cardinal Health has a long-standing relationship with government procurement, as evidenced by its extensive experience in the DLA's Pharmaceutical Prime Vendor program. The company also holds a separate indefinite delivery contract (IDC) with the Department of Veterans Affairs (VA) for the provision of radiopharmaceutical products used in medical imaging procedures within the VA healthcare system. This IDC, valued at $773,677.24, highlights Cardinal Health's specialized capabilities in handling and distributing time-sensitive, radioactive medical products. Additionally, Cardinal Health's subsidiary, The Harvard Drug Group, L.L.C., secured a single-award IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets, further demonstrating the company's ability to manage large-scale, multi-agency pharmaceutical supply agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $151.7k | 5/13/15 |